PF-06424439 is a potent and selective inhibitor of diacylglycerol acyltransferase 2 (DGAT2).

T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells.

Cell-permeable, biologically active ceramide.

Nelfinavir is a synthetic Protease Inhibitor that selectively binds to and inhibits human immunodeficiency virus (HIV) protease. Nelfinavir has activity against HIV 1 and 2.

Daclatasvirr 2HCl is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C.

Velpatasvir is a Hepatitis C Virus NS5A Inhibitor.

AEBSF HCl is a broad spectrum, irreversible serine protease inhibitor.

Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.